{"title":"Clarification: ACE inhibitors and angiotensin II receptor antagonists","public_updated_at":"2014-12-11T14:27:02Z","details":{"metadata":{"therapeutic_area":["cardiovascular-disease-lipidology"],"first_published_at":"2009-07-01T00:00:00Z","bulk_published":true,"document_type":"drug_safety_update"},"change_history":[{"id":70568,"note":"First published.","public_timestamp":"2014-12-11T14:27:02Z","edition_id":778651,"created_at":"2017-05-12T10:05:04Z","updated_at":"2017-05-12T10:05:04Z","content_id":"bb8a4df9-0305-4060-b096-8ac7f4353c18"}],"body":[{"content_type":"text/html","content":"<p>Article date: July 2009</p>\n\n<p>We have received some feedback and queries about our drug safety advice article on the use of ACE inhibitors and angiotensin II receptor antagonists during breastfeeding, which was published in the <a rel=\"external\" href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ssLINK/CON088003\">May 2009 issue of the bulletin</a>.</p>\n\n<p>We would like to clarify that although ACE inhibitors and angiotensin II receptor antagonists are generally not recommended for use by breastfeeding mothers, they are not absolutely contraindicated. Healthcare professionals may prescribe these medicines during breastfeeding if they consider that this treatment is essential for the lactating mother. In particular, the original article advised that in mothers who are breastfeeding older infants, the use of captopril, enalapril, or quinapril may be considered if an ACE inhibitor is necessary for the mother. Careful follow-up of the infant for possible signs of hypotension is recommended.</p>\n\n<p>Article citation: Drug Safety Update July 2009, vol 2 issue 12: 10a.</p>\n"},{"content_type":"text/govspeak","content":"Article date: July 2009\r\n\r\nWe have received some feedback and queries about our drug safety advice article on the use of ACE inhibitors and angiotensin II receptor antagonists during breastfeeding, which was published in the [May 2009 issue of the bulletin](http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ssLINK/CON088003).\r\n\r\nWe would like to clarify that although ACE inhibitors and angiotensin II receptor antagonists are generally not recommended for use by breastfeeding mothers, they are not absolutely contraindicated. Healthcare professionals may prescribe these medicines during breastfeeding if they consider that this treatment is essential for the lactating mother. In particular, the original article advised that in mothers who are breastfeeding older infants, the use of captopril, enalapril, or quinapril may be considered if an ACE inhibitor is necessary for the mother. Careful follow-up of the infant for possible signs of hypotension is recommended.\r\n\r\nArticle citation: Drug Safety Update July 2009, vol 2 issue 12: 10a.\r\n"}],"max_cache_time":10},"routes":[{"path":"/drug-safety-update/clarification-ace-inhibitors-and-angiotensin-ii-receptor-antagonists","type":"exact"}],"redirects":[],"publishing_app":"specialist-publisher","rendering_app":"government-frontend","need_ids":[],"phase":"live","analytics_identifier":null,"document_type":"drug_safety_update","schema_name":"specialist_document","first_published_at":"2016-02-29T09:24:10Z","base_path":"/drug-safety-update/clarification-ace-inhibitors-and-angiotensin-ii-receptor-antagonists","description":"Use during breastfeeding","content_id":"bb8a4df9-0305-4060-b096-8ac7f4353c18","locale":"en","expanded_links":{"organisations":[{"analytics_identifier":"EA63","api_path":"/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency","base_path":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","description":null,"document_type":"organisation","locale":"en","public_updated_at":"2015-06-29T14:33:29Z","schema_name":"placeholder","title":"Medicines and Healthcare products Regulatory Agency","withdrawn":false,"details":{"brand":"department-of-health","logo":{"formatted_title":"Medicines &amp; Healthcare products<br/>Regulatory Agency","crest":"single-identity"}},"links":{}}],"finder":[{"analytics_identifier":null,"api_path":"/api/content/drug-safety-update","base_path":"/drug-safety-update","content_id":"602be505-4cf4-4f8c-8bfc-7bc4b63a7f47","description":"Find drug safety updates issued by MHRA","document_type":"finder","locale":"en","public_updated_at":"2017-03-30T10:34:00Z","schema_name":"finder","title":"Drug Safety Update","withdrawn":false,"details":{"document_noun":"update","filter":{"document_type":"drug_safety_update"},"format_name":"Drug Safety Update","show_summaries":true,"facets":[{"key":"therapeutic_area","name":"Therapeutic area","type":"text","preposition":"about","display_as_result_metadata":true,"filterable":true,"allowed_values":[{"label":"Anaesthesia and intensive care","value":"anaesthesia-intensive-care"},{"label":"Cancer","value":"cancer"},{"label":"Cardiovascular disease and lipidology","value":"cardiovascular-disease-lipidology"},{"label":"Dentistry","value":"dentistry"},{"label":"Dermatology","value":"dermatology"},{"label":"Ear, nose and throat","value":"ear-nose-throat"},{"label":"Endocrinology, diabetology and metabolism","value":"endocrinology-diabetology-metabolism"},{"label":"GI, hepatology and pancreatic disorders","value":"gi-hepatology-pancreatic-disorders"},{"label":"Haematology","value":"haematology"},{"label":"Immunology and vaccination","value":"immunology-vaccination"},{"label":"Immunosuppression and transplantation","value":"immunosuppression-transplantation"},{"label":"Infectious disease","value":"infectious-disease"},{"label":"Neurology","value":"neurology"},{"label":"Nutrition and dietetics","value":"nutrition-dietetics"},{"label":"Obstetrics, gynaecology and fertility","value":"obstetrics-gynaecology-fertility"},{"label":"Ophthalmology","value":"ophthalmology"},{"label":"Paediatrics and neonatology","value":"paediatrics-neonatology"},{"label":"Pain management and palliation","value":"pain-management-palliation"},{"label":"Psychiatry","value":"psychiatry"},{"label":"Radiology and imaging","value":"radiology-imaging"},{"label":"Respiratory disease and allergy","value":"respiratory-disease-allergy"},{"label":"Rheumatology","value":"rheumatology"},{"label":"Urology and nephrology","value":"urology-nephrology"}]},{"key":"first_published_at","name":"Published","short_name":"Published","type":"date","preposition":"published","display_as_result_metadata":true,"filterable":true}],"default_documents_per_page":50},"links":{}}],"available_translations":[{"title":"Clarification: ACE inhibitors and angiotensin II receptor antagonists","public_updated_at":"2014-12-11T14:27:02Z","analytics_identifier":null,"document_type":"drug_safety_update","schema_name":"specialist_document","base_path":"/drug-safety-update/clarification-ace-inhibitors-and-angiotensin-ii-receptor-antagonists","description":"Use during breastfeeding","api_path":"/api/content/drug-safety-update/clarification-ace-inhibitors-and-angiotensin-ii-receptor-antagonists","withdrawn":false,"content_id":"bb8a4df9-0305-4060-b096-8ac7f4353c18","locale":"en"}]},"format":"specialist_document","navigation_document_supertype":"other","user_journey_document_supertype":"thing","email_document_supertype":"other","government_document_supertype":"other","payload_version":0}